Evidence map›Paper›PMID 28783078›Full record

ReviewInternational journal of molecular sciences2017

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.

Silvia Vandini, Carlotta Biagi, Marcello Lanari

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Review
  12. Immunofocusing design of a fusion glycoprotein monomer vaccine for respiratory syncytial virus.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. RSV: an overview of infection in adults.Pneumonia (Nathan Qld.) · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Silvia VandiniPediatrics and Neonatology Unit, Imola Hospital, 40026 Imola, Italy. s.vandini@ausl.imola.bo.it.
Carlotta BiagiDepartment of Pediatric Emergency, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy. Carlotta.biagi2@unibo.it.
Marcello LanariDepartment of Pediatric Emergency, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy. marcello.lanari@unibo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) belongs to the recently defined

Indexed as

SerogroupGenetic VariationGenotypeHumansRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus Infectionsbronchiolitischildrengenotypelower respiratory tract infectionsmonoclonal antibodiesrespiratory syncytial virusvaccines

Identifiers

PMID28783078
PMCPMC5578107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.